Quick Takeaways
- Lind Global Fund II LP filed SCHEDULE 13G/A for TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX).
- Disclosed ownership: 8.8%.
- Date of event: 30 Sep 2025.
Lind Global Fund II LP - 30 Sep 2025 SCHEDULE 13G/A Report for TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX)
- Filing Manager
- Lind Global Fund II LP
- Reporting Manager
- Lind Global Fund II LP
- Symbol
- TENX
- Shares outstanding
- 5,028,182 shares
- Disclosed Ownership
- 442,480 shares
- Ownership
- 8.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 16:10:50 UTC
- Date of event
- 30 Sep 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Lind Global Fund II LP disclosed 8.8% ownership in TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 16:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Lind Global Fund II LP | 8.8% | 442,480 | 442,480 | 0 | By: Lind Global Partners II LLC, its General Partner, By: /s/ Jeff Easton | Jeff Easton, Managing Member | |
| Lind Global Partners II LLC | 8.8% | 442,480 | 442,480 | 0 | /s/ Jeff Easton | Jeff Easton, Managing Member | |
| EASTON JEFF | 8.8% | 442,480 | 442,480 | 0 | /s/ Jeff Easton | Jeff Easton |